PTK2B and colorectal carcinoma: To determine the responses of CRC cells to signaling inhibitors, we screened the responses of 10 CRC cell lines to a panel of 8 PTK inhibitors, and a Mek kinase inhibitor and a PI 3-kinase inhibitor.